Poloxamer and poloxamine compositions for nucleic acid delivery
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 19, 2006
app pub date -
Sep 1, 2005
filing date -
Mar 3, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention features selected polymers such as poloxamer 188 (Pluronic.RTM. F68), poloxamer 237 (Pluronic.RTM. F87), poloxamer 401 (Pluronic.RTM. L121), poloxamer 338 (Pluronic.RTM. F108), Poloxamer 124 (Pluronic.RTM. L44), Poloxamer 184 (L-64), and poloxamines (Tetronics.RTM. 904, 908, 1107, and 90R4) that enhance expression from nucleic acids when administered into an organism, in particular to muscle, and further provides selected poloxamer formulations for delivery of nucleic acids to the liver.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully